Effects of Non-statin Lipid-Lowering Therapies Implementation and Statin Treatment Intensification on Lipid Status in Heart Transplant Recipients: A Single-Centre Retrospective Cohort Study [0.03%]
非他汀类降脂疗法和强化他汀治疗对心脏移植受者血脂水平影响的单中心回顾性队列研究
Daniela Bacich,Enrico Giuseppe Italiano,Marika Faggioli et al.
Daniela Bacich et al.
Introduction: Statin therapy up-titration is hindered in heart-transplant (HT) recipients due to concern for pharmacological interactions and side effects. Alternative lipid lowering therapies (LLT) are now available for ...
Association Between Naples Prognostic Score and All-Cause Mortality in Individuals with Cardio-Renal-Metabolic Multimorbidity: A Cohort Study [0.03%]
那不勒斯预后评分与心血管-肾脏-代谢多病共存个体全因死亡率之间的关联：一项队列研究
Song Wen,Wei Shi,Xingjie Huang et al.
Song Wen et al.
Introduction: The Naples Prognostic Score (NPS) has demonstrated prognostic value in oncology and certain chronic diseases. Its utility in cardio-renal-metabolic multimorbidity (CRMM) remains unexplored. ...
Validation of Risk Perception Cut-Offs in Italian Brief PRHDS (PRHDS-BI): Implications for Primary Cardiovascular Prevention [0.03%]
意大利简短版PRHDS（PRHDS-BI）风险感知临界值的验证：对一级心血管预防的影响
Rosa Debora,Adorni Roberta,Trenta Alessia et al.
Rosa Debora et al.
Introduction: Effective cardiovascular (CV) prevention requires accurate risk estimation and patient engagement, which depends on perceived risk. The Perception of Risk of Heart Disease Scale (PRHDS) is a validated tool, ...
Thoracoscopic Sympathectomy in Treatment-Resistant Essential Hypertension: A Novel Approach to Reduce Sympathetic Activity and Blood Pressure [0.03%]
电视交感神经切断术治疗难治性原发性高血压的疗效观察
Mark Reinhard,Amal Derai,Niels Henrik Buus et al.
Mark Reinhard et al.
Prognostic Value of Albumin/Globulin Ratio for Mortality in Stage 2 Cardiovascular-Kidney-Metabolic Syndrome: A Nationwide Cohort Analysis (1999-2018) [0.03%]
白蛋白/球蛋白比值对心血管-肾脏-代谢综合征2期患者死亡率的预后价值：一项全国队列分析（1999-2018）
Ciai Chen,Shanni Ding,Yao Wang et al.
Ciai Chen et al.
Introduction: Cardiovascular-kidney-metabolic (CKM) syndrome represents a complex interplay of metabolic dysfunction, cardiovascular disease, and chronic kidney disease, with stage 2 characterized by metabolic risk factor...
Cardiac Organ Damage in Young Adults with Cryptogenic Ischaemic Stroke: The SECRETO Study [0.03%]
青年隐源性缺血性卒中患者的心脏器质性疾病：SECRETO研究
Rune Krogh Eilertsen,Eva Gerdts,Ulrike Waje-Andreassen et al.
Rune Krogh Eilertsen et al.
Introduction: Cardiac organ damage (OD) is associated with increased risk of cardiovascular disease. However, limited knowledge exists on cardiac OD in young patients with cryptogenic ischaemic stroke (CIS). ...
Adherence to Hypertension Medications During the First Year of Treatment in Elderly Patients and its Effect on Clinical Outcomes [0.03%]
老年患者治疗一年期间的高血压药物依从性及其对临床结果的影响
Ophir Lavon,Sinan Omri
Ophir Lavon
Introduction: Adherence to antihypertensive medications is essential to ensure therapeutic effectiveness. However, the long-term clinical impact of adherence during the first year of treatment in elderly patients remains ...
Lack of regional and whole body sympathetic normalization during antihypertensive drug treatment: a potential link for the residual risk [0.03%]
抗高血压药物治疗过程中区域及全身交感神经不稳定性：与残余风险的潜在联系
Guido Grassi,Rita Facchetti,Ana Jelakovic et al.
Guido Grassi et al.
Introduction: It is unknown whether the failure of antihypertensive drug treatment to normalize sympathetic cardiovascular (CV) function reported in previous studies selectively affects regional sympathetic CV outflow or ...
Renal Functional Reserve and Its Association with eGFR Trajectories and Blood Pressure Patterns in Hypertensives with Preserved Renal Function [0.03%]
preserved肾功能高血压患者的功能储备及其与eGFR轨迹和血压模式的关联
Aikaterini Damianaki,Kyriakos Dimitriadis,Emelina Stambolliu et al.
Aikaterini Damianaki et al.
Introduction: Renal Functional Reserve (RFR) is a promising marker for detecting early nephron loss and functional renal mass. Aim: We ...
Lipoprotein(a) Does Not Correlate with Hypertensive Mediated Organ Damage and Subsequent Cardiovascular Events in a Primary Prevention Cohort [0.03%]
脂蛋白(a)与原发性预防队列中高血压介导的器官损害及随后的心血管事件无关
Chiara Tognola,Davide Paolo Bernasconi,Paola Rebora et al.
Chiara Tognola et al.
Introduction: Elevated lipoprotein(a) [Lp(a)] levels have been strongly related to cardiovascular (CV) risk. However, its association with Hypertension Mediated Organ Damage (HMOD) and CV events in the primary prevention ...